RCUS
Arcus Biosciences Inc
24.90$
-0.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.1% | +367.7% | -73.1% | +23.1% | -45.8% | +7.7% | +471.4% | -83.8% | +26.9% | -48.5% | +141.2% | – | |
| – | +66.7% | -40.0% | -33.3% | – | – | – | – | +0.0% | +50.0% | -33.3% | – | – | |
| – | -3.1% | +367.7% | -73.1% | +23.1% | -45.8% | +7.7% | +471.4% | -85.0% | +25.0% | -50.0% | +173.3% | – | |
| – | +13.4% | +17.2% | +5.5% | +7.0% | -17.9% | +20.8% | +13.9% | +1.4% | -14.2% | +0.8% | -7.4% | – | |
| – | -3.3% | +10.3% | -6.3% | +0.0% | -6.7% | +0.0% | +3.6% | -6.9% | -3.7% | +11.5% | -17.2% | – | |
| – | +8.9% | +32.0% | -9.9% | +5.5% | -15.7% | +16.3% | +12.0% | -1.2% | -13.3% | +3.5% | -8.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +100.0% | -50.0% | -100.0% | – | +100.0% | -50.0% | +100.0% | +50.0% | +366.7% | -78.6% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -50.0% | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -1,400.0% | – | – | – | – | -3,350.0% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.